These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 10914623)

  • 21. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
    Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
    Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
    Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML; Wagner RM; Slotnick RN
    Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
    Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
    Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
    Odibo AO; Sehdev HM; Stamilio DM; Macones GA
    Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
    Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
    Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
    Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
    Saller DN; Canick JA; Blitzer MG; Palomaki GE; Schwartz S; Blakemore KJ; Haddow JE
    Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
    Gravett CP; Buckmaster JG; Watson PT; Gravett MG
    Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
    Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
    Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
    Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
    Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers.
    Pergament E; Stein AK; Fiddler M; Cho NH; Kupferminc MJ
    Obstet Gynecol; 1995 Aug; 86(2):255-8. PubMed ID: 7542379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.